Brett Kaplan SEC EDGAR Filings (CIK 0001778763)

SEC EDGAR filings, ownership reports, and insider transactions for Brett Kaplan.

Business address
C/O Prevail Therapeutics Inc., 430 East 29 Th Street, Suite 940, New York, NY, 10016
Top holdings (ownership)
CLYM
Get insider transactions for this reporting owner
Brett Kaplan has filed 9 SEC EDGAR filings since 19 Jun 2019

Latest Filings

Recent SEC filings for Brett Kaplan including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 15 Jan 2025 13 Jan 2025 001-40708
4 Open 4 document View SEC filing for 4 4 26 Aug 2024 26 Aug 2024 001-40708
3 Open 3 document View SEC filing for 3 3 26 Aug 2024 26 Aug 2024 001-40708
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 23 Feb 2022 18 Feb 2022 001-39696
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 Jan 2021 22 Jan 2021 001-38939
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 14 Sep 2020 10 Sep 2020 000-55939
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 14 Sep 2020 10 Sep 2020 000-55939
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 11 Mar 2020 19 Feb 2020 001-38939
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 19 Jun 2019 19 Jun 2019 001-38939

About this filer

Brett Kaplan files with the SEC under CIK 0001778763. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages